Recessive Parkinson's disease
- PMID: 16615060
- DOI: 10.1002/mds.20841
Recessive Parkinson's disease
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disease caused by loss of dopaminergic neurons in the substantia nigra pars compacta. Although the etiology of PD remains unclear, it is now clear that genetic factors contribute to the pathogenesis of the disease. Recently, several causative genes have been identified in monogenic forms of PD. Accumulating evidence indicates that their gene products play important roles in mitochondrial function, oxidative stress response, and the ubiquitin-proteasome system, which are also implicated in sporadic PD, suggesting that these gene products share a common pathway to nigral degeneration in both familial and sporadic PD. Here, we review recent advances in knowledge about genes associated with recessive PD, including parkin, PINK1, and DJ-1.
(c) 2006 Movement Disorder Society.
Similar articles
-
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Exp Neurol. 2009. PMID: 19303005 Review.
-
Familial Parkinson's disease: a hint to elucidate the mechanisms of nigral degeneration.J Neurol. 2003 Oct;250 Suppl 3:III2-10. doi: 10.1007/s00415-003-1302-y. J Neurol. 2003. PMID: 14579118 Review.
-
[Parkin and mitochondria].Brain Nerve. 2008 Aug;60(8):923-9. Brain Nerve. 2008. PMID: 18717196 Review. Japanese.
-
New aspects of genetic contributions to Parkinson's disease.J Mol Neurosci. 2004;24(3):417-24. doi: 10.1385/JMN:24:3:417. J Mol Neurosci. 2004. PMID: 15655263 Review.
-
[The role of parkin in Parkinson's disease].Neuropsychopharmacol Hung. 2014 Jun;16(2):67-76. Neuropsychopharmacol Hung. 2014. PMID: 24978049 Review. Hungarian.
Cited by
-
Genetic analysis of coding SNPs in blood-brain barrier transporter MDR1 in European Parkinson's disease patients.J Neural Transm (Vienna). 2009 Apr;116(4):443-50. doi: 10.1007/s00702-009-0196-y. Epub 2009 Mar 3. J Neural Transm (Vienna). 2009. PMID: 19255821
-
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes.J Neurol. 2008 Sep;255(9):1372-7. doi: 10.1007/s00415-008-0923-6. Epub 2008 Jul 3. J Neurol. 2008. PMID: 18584234 Clinical Trial.
-
Precision Dopaminergic Treatment in a Cohort of Parkinson's Disease Patients Carrying Autosomal Recessive Gene Variants: Clinical Cohort Data and a Mini Review.Neurol Int. 2024 Jul 30;16(4):833-844. doi: 10.3390/neurolint16040062. Neurol Int. 2024. PMID: 39195564 Free PMC article.
-
Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism.Helicobacter. 2010 Aug;15(4):279-94. doi: 10.1111/j.1523-5378.2010.00768.x. Helicobacter. 2010. PMID: 20633189 Free PMC article. Clinical Trial.
-
Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.J Neural Transm (Vienna). 2017 Apr;124(4):407-415. doi: 10.1007/s00702-017-1688-9. Epub 2017 Feb 3. J Neural Transm (Vienna). 2017. PMID: 28160151
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous